Giulio Marchesini
Giulio Marchesini
Professor of Medicine, University of Bologna
Verified email at unibo.it
Title
Cited by
Cited by
Year
Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes
B Zinman, C Wanner, JM Lachin, D Fitchett, E Bluhmki, ...
New England Journal of Medicine 373 (22), 2117-2128, 2015
72732015
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
G Marchesini, E Bugianesi, G Forlani, F Cerrelli, M Lenzi, R Manini, ...
Hepatology 37 (4), 917-923, 2003
31382003
Nonalcoholic fatty liver disease: a feature of the metabolic syndrome
G Marchesini, M Brizi, G Bianchi, S Tomassetti, E Bugianesi, M Lenzi, ...
Diabetes 50 (8), 1844-1850, 2001
29872001
Empagliflozin and progression of kidney dsease in type 2 diabetes
C Wanner, SE Inzucchi, JM Lachin, D Fitchett, M von Eynatten, ...
New england journal of medicine 375 (4), 323-334, 2016
23342016
The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD
P Angulo, JM Hui, G Marchesini, E Bugianesi, J George, GC Farrell, ...
Hepatology 45 (4), 846-854, 2007
22652007
Association of nonalcoholic fatty liver disease with insulin resistance
G Marchesini, M Brizi, AM Morselli-Labate, G Bianchi, E Bugianesi, ...
The American journal of medicine 107 (5), 450-455, 1999
19471999
Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma
E Bugianesi, N Leone, E Vanni, G Marchesini, F Brunello, P Carucci, ...
Gastroenterology 123 (1), 134-140, 2002
17082002
Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study
G Bedogni, L Miglioli, F Masutti, C Tiribelli, G Marchesini, S Bellentani
Hepatology 42 (1), 44-52, 2005
16142005
A position statement on NAFLD/NASH based on the EASL 2009 special conference
V Ratziu, S Bellentani, H Cortez-Pinto, C Day, G Marchesini
Journal of hepatology 53 (2), 372-384, 2010
11412010
A randomized, controlled trial of 3.0 mg of liraglutide in weight management
X Pi‑Sunyer, A Astrup, K Fujioka, F Greenway, A Halpern, M Krempf, ...
New England Journal of Medicine 373 (1), 11-22, 2015
10732015
Metformin in non-alcoholic steatohepatitis
G Marchesini, G Bianchi, S Tomassetti, M Zoli, N Melchionda
The Lancet 358 (9285), 893-894, 2001
9972001
Insulin resistance: a metabolic pathway to chronic liver disease
E Bugianesi, AJ McCullough, G Marchesini
Hepatology 42 (5), 987-1000, 2005
9312005
Clinical features and natural history of nonalcoholic steatosis syndromes
Y Falck-Ytter, ZM Younossi, G Marchesini, AJ McCullough
Seminars in liver disease 21 (1), 15-22, 2001
9152001
EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease
G Marchesini, CP Day, JF Dufour, A Canbay, V Nobili, V Ratziu, H Tilg, ...
Journal of Hepatology 64 (6), 1388-1402, 2016
867*2016
A Randomized Controlled Trial of Metformin versus Vitamin E or Prescriptive Diet in Nonalcoholic Fatty Liver Disease
E Bugianesi, E Gentilcore, R Manini, S Natale, E Vanni, N Villanova, ...
The American journal of gastroenterology 100 (5), 1082, 2005
8662005
EASL-EASD-EASO Clinical Practice Guidelines for the management of nonalcoholic fatty liver disease
EA the Study of the Liver (EASL), EA the Study of Diabetes (EASD), ...
Journal of Hepatology 64 (6), 1388-1402, 2016
863*2016
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
European Association for The Study of The Liver, ...
Obesity facts 9 (2), 65-90, 2016
8632016
Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease
N Villanova, S Moscatiello, S Ramilli, E Bugianesi, D Magalotti, E Vanni, ...
Hepatology 42 (2), 473-480, 2005
7072005
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes
AL Fracanzani, L Valenti, E Bugianesi, M Andreoletti, A Colli, E Vanni, ...
Hepatology 48 (3), 792-798, 2008
6922008
A survey of adverse events in 11241 patients with chronic viral hepatitis treated with alfa interferon
G Fattovich, G Giustina, S Favarato, A Ruol, ...
Journal of Hepatology 24 (1), 38-47, 1996
6111996
The system can't perform the operation now. Try again later.
Articles 1–20